LBIO (Longevity Biomedical) Cash Flow for Dividends: $0.00 Mil (TTM As of . 20)


What is Longevity Biomedical Cash Flow for Dividends?

Longevity Biomedical LBIO Cash Flow for Dividends is $0.00 Mil as of . 20.

Longevity Biomedical's cash flow for dividends for the six months ended in . 20 was $0.00 Mil. Its cash flow for dividends for the trailing twelve months (TTM) ended in . 20 was $0.00 Mil.

Note: A negative number here means the payment of dividends. When pays more dividends, the absolute value gets bigger.

Longevity Biomedical Cash Flow for Dividends Related Terms

Longevity Biomedical Cash Flow for Dividends Historical Data

* Premium members only.

The historical data trend for Longevity Biomedical's Cash Flow for Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Longevity Biomedical Cash Flow for Dividends Chart

Longevity Biomedical Annual Data
Trend
Cash Flow for Dividends

Longevity Biomedical Semi-Annual Data
Cash Flow for Dividends

Longevity Biomedical Cash Flow for Dividends Calculation

Cash flow for dividends refers to the payment of cash to shareholders as dividends when the company generates income.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. Cash Flow for Dividends for the trailing twelve months (TTM) ended in . 20 was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Cash Flow for Dividends of $0.00 Mil mean?
Longevity Biomedical (LBIO) has a Cash Flow for Dividends of $0.00 Mil as of . 20. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Longevity Biomedical and its competitors.
Is Longevity Biomedical's Cash Flow for Dividends too high?
Longevity Biomedical's current Cash Flow for Dividends is $0.00 Mil.
How does Longevity Biomedical's Cash Flow for Dividends compare to ?
Longevity Biomedical's Cash Flow for Dividends of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cash Flow for Dividends for a Biotechnology company?
A good Cash Flow for Dividends depends on the Biotechnology industry context. However, Cash Flow for Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cash Flow for Dividends mean?
A high Cash Flow for Dividends can signal that a stock is expensive relative to its fundamentals. Cash Flow for Dividends represent the amount a company pays as dividends for a specific accounting period. View historical data for Longevity Biomedical and its competitors. Longevity Biomedical's current Cash Flow for Dividends is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Longevity Biomedical stock overvalued right now?
Longevity Biomedical (LBIO) has a current Cash Flow for Dividends of $0.00 Mil. The current Cash Flow for Dividends is $0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cash Flow for Dividends calculated?
Cash Flow for Dividends is calculated from a company's financial statements. For Longevity Biomedical (LBIO), the current Cash Flow for Dividends is $0.00 Mil as of . 20. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Longevity Biomedical Business Description

Comparable Companies
Address 12100 NE 195th street, Suite 150, Bothell, WA, USA, 98011
Longevity Biomedical Inc is a clinical-stage biomedical company. The company is focused on the advancement of new technologies across therapeutics, monitoring, and digital health that aim to restore tissue form and function to increase health span. Longevity is acquiring a differentiated therapeutic pipeline of late-stage clinical technologies across ophthalmology, cardiovascular disease, and soft tissue reconstruction and repair.